Micoli, Francesca
GlaxoSmithKline SpA,
Italy
2025 Rank: 157507
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Microbiology
SubField 2:
Immunology
Rank in SubField 1: 3097 out of 217955 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 157507 | 107757 |
| Total Cites | 477 | 678 |
| H-index | 10 | 12 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 25 | 25 |
| Total Cites to Single+First Authored Papers | 266 | 332 |
| Number of Single+First+Last Authored Papers | 70 | 70 |
| Total Cites to Single+First+Last Authored Papers | 398 | 534 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 342 | 368 |
| Ratio of Total Citations to Distinct Citing Papers | 1.39 | 1.84 |
| Self-Citation Percentage |
29.65%
|
|
Micoli, Francesca
GlaxoSmithKline SpA,
Italy
2024 Rank: 148758
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Microbiology
SubField 2:
Immunology
Rank in SubField 1: 3147 out of 204759 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 148758 | 103216 |
| Total Cites | 436 | 614 |
| H-index | 10 | 13 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 24 | 24 |
| Total Cites to Single+First Authored Papers | 236 | 298 |
| Number of Single+First+Last Authored Papers | 63 | 63 |
| Total Cites to Single+First+Last Authored Papers | 342 | 463 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 289 | 311 |
| Ratio of Total Citations to Distinct Citing Papers | 1.51 | 1.97 |
| Self-Citation Percentage |
28.99%
|
|
Micoli, Francesca
GlaxoSmithKline SpA,
Italy
2023 Rank: 250085
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Microbiology
SubField 2:
Immunology
Rank in SubField 1: 5667 out of 190396 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 250085 | 154672 |
| Total Cites | 309 | 495 |
| H-index | 8 | 11 |
| Hm-index | 3 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 163 | 232 |
| Number of Single+First+Last Authored Papers | 53 | 53 |
| Total Cites to Single+First+Last Authored Papers | 246 | 375 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 223 | 247 |
| Ratio of Total Citations to Distinct Citing Papers | 1.39 | 2.00 |
| Self-Citation Percentage |
37.58%
|
|
Micoli, Francesca
GlaxoSmithKline SpA,
Italy
2022 Rank: 233818
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Microbiology
SubField 2:
Organic Chemistry
Rank in SubField 1: 5436 out of 175943 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 233818 | 129191 |
| Total Cites | 282 | 493 |
| H-index | 8 | 12 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 126 | 195 |
| Number of Single+First+Last Authored Papers | 43 | 43 |
| Total Cites to Single+First+Last Authored Papers | 209 | 362 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 169 | 197 |
| Ratio of Total Citations to Distinct Citing Papers | 1.67 | 2.50 |
| Self-Citation Percentage |
42.80%
|
|
Related Profiles
.jpg)
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.